mva-ebo z
Vaccineexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02354404)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- MarburgvirusImmunity, active
Marburgvirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva-ebo z
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02485912 | Phase 1 | Jul 1, 2015 | Centre Hospitalier Universitaire le Dantec, University of Oxford |
| NCT02451891 | Phase 1 | Apr 1, 2015 | University of Oxford |
| NCT02368119 | Phase 1 | Mar 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), University of Maryland |
| NCT02354404 | Phase 1 | Jan 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), The EMMES Corporation, United States Army |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 1 | 1 | 2015 |
| University of Oxford | Academic/Hospital | 2 | 2 | 1 | 2015 |
| Centre Hospitalier Universitaire le Dantec | Academic/Hospital | 1 | 0 | 1 | 2015 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2015 |
| The EMMES Corporation | For profit | 1 | 0 | 1 | 2015 |
| United States Army | Government | 1 | 0 | 1 | 2015 |
| University of Maryland | Academic/Hospital | 1 | 1 | 1 | 2015 |
7 organizations
Page 1 / 1